Introduction
TB-500 (a synthetic of thymosin beta-4, 43 amino acids) and TB-500 Fragment 17-23 (the minimal active domain, 7 amino acids) both derive from the same parent protein but differ in size, tissue distribution, and potentially in their spectrum of biological activity. The fragment represents the core actin-binding domain (LKKTETQ) identified as the minimum sequence required for G-actin sequestration and cell migration activity.
Mechanism of Action Comparison
Full-length TB-500 retains the complete active region of thymosin beta-4, including the actin-binding domain, N-terminal sequences involved in anti-inflammatory signaling, and C-terminal regions implicated in stem cell activation and cardiac repair. Its larger size provides multiple functional domains that work in concert.
TB-500 Fragment 17-23 (LKKTETQ) isolates the actin-binding domain responsible for G-actin sequestration. By binding monomeric actin, it promotes the depolymerization of filamentous actin, increasing cell motility and enabling cells to migrate into injured tissue. The fragment's smaller size may offer advantages in tissue penetration and localized research applications.
Key Differences
| Feature | TB-500 | TB-500 Fragment 17-23 |
|---|---|---|
| Size | 43 amino acids | 7 amino acids |
| Actin Binding | Full domain + flanking regions | Core LKKTETQ domain only |
| Anti-inflammatory | Multiple mechanisms | Primarily via cell migration |
| Stem Cell Activation | Documented | Not established |
| Cardiac Repair | Well-studied | Limited data |
| Tissue Penetration | Standard for size | Potentially enhanced (smaller) |
Research Applications
Full-length TB-500 is the standard for comprehensive tissue healing research, cardiac repair studies, and protocols leveraging the complete thymosin beta-4 activity profile. TB-500 Fragment 17-23 is used in targeted actin biology research, structure-activity studies of thymosin beta-4, and investigations where isolating the actin-binding function is desired. The fragment is also combined with BPC-157 in certain healing blend formulations.
Which to Choose for Your Research?
For broad tissue healing research requiring the full spectrum of thymosin beta-4 activity (including anti-inflammatory, stem cell, and cardiac effects), full-length TB-500 is preferred. For focused actin-binding studies, structure-activity research, or protocols where a smaller, more penetrant peptide is advantageous, TB-500 Fragment 17-23 provides the minimal functional unit. Both are valid tools depending on the specificity of your research question.
